24 Jan 2020 - The Australian share market rose at the open although closed flat for the end of the week. Shares in Insurance Australia (ASX:IAG) took a tumble, following the insurer’s warning to shareholders on recent claims.
Phoslock Environmental Technologies (ASX:PET) issues Coronavirus impact update: Aus shares 0.4% higher at noon
24 Jan 2020 - The Australian share market rose at the open. Downer (ASX:DOW) and Cimic (ASX:CIM) are leading the gains this morning after plummeting yesterday. Prospa Group (ASX:PGL) appoint interim CFO.
24 Jan 2020 - The Board of Virtus Health (ASX:VRT) is pleased to announce that they have appointed a new Group Chief Executive Officer.
24 Jan 2020 - Village Roadshow (ASX:VRL) has received a second take-over bid, this time from BGH Capital.
24 Jan 2020 - Genworth Mortgage lnsurance Australia (ASX:GMA) today announced that Pauline Blight-Johnston has been appointed Chief Executive Officer and Managing Director.
24 Jan 2020 - Domain Holdings Australia (ASX:DHG) today announced the appointment of Hugh Marks and Lizzie Young as Non-Executive Directors of Domain.
24 Jan 2020 - Following positive leads from US markets, the ASX looks set to open higher despite more people infected by the virus in China that’s rocked the markets. The World Health Organisation says it is “a bit too early” to declare a new coronavirus a global health emergency. Nuheara (ASX:NUH) has executed an agreement for $2.5 million funding with the Lind Global Macro Fund.
24 Jan 2020 - Oceania Healthcare (ASX:OCA) released their half yearly accounts showing net profit after tax was 17.6 per cent up from the first half of 2019 for the six months to 30 November 2019.
24 Jan 2020 - Wesfarmers (ASX:WES) says they have completed a definitive feasibility study (DFS) on the Mt Holland lithium project but a final investment decision has been deferred.
23 Jan 2020 - It has been a negative day of trade for the ASX closing 0.6% lower. Shares shot up for National Storage REIT (ASX:NSR) after they confirmed they had received a takeover offer from private equity fund manager Gaw Capital Partners. And Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration has approved the ZIRCON study for recruitment of American patients.